Aarti Drugs Ltd., established in 1984, is a key player in the Aarti Group of Industries, with a total group value of $900 million. They operate in the pharmaceutical sector, producing Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals, and Formulations through their subsidiary, Pinnacle Life Science Private Limited. Their product range includes various pharmaceutical ingredients and specialty chemicals. The company is known for its quality manufacturing and holds Good Manufacturing Practices (GMP) certifications. They are also in the process of securing ISO 9002 compliance. With government initiatives promoting private health insurance, Aarti Drugs Ltd. aims to expand its market presence by offering high-quality products with timely delivery, capitalizing on the expected growth in the generic pharmaceutical sector.